| Dexamethasone‐mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells HMM Ahmed, SC Nimmagadda, YS Al‐Matary, M Fiori, T May, D Frank, ... British Journal of Haematology 196 (4), 995-1006, 2022 | 13 | 2022 |
| Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells L Heinemann, KM Möllers, HMM Ahmed, L Wei, K Sun, SC Nimmagadda, ... Frontiers in Oncology 12, 874325, 2022 | 5 | 2022 |
| Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCs X Xie, PK Patnana, D Frank, J Schütte, Y Al-Matary, A Künstner, H Busch, ... Frontiers in Cell and Developmental Biology 11, 866847, 2023 | 1 | 2023 |
| Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition J Vorwerk, K Sun, D Frank, F Neumann, J Hüve, PM Budde, L Liu, X Xie, ... Frontiers in Oncology 12, 903691, 2022 | 1 | 2022 |
| Comparison between cirrhotic HCC patients versus non-cirrhotic HCC patients. Y Rostom, MY Gouda, A Al-Nabhi, R Elsaka, H Noman Pan Arab Journal of Oncology 10 (1), 2017 | 1 | 2017 |
| Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy D Frank, PK Patnana, J Vorwerk, L Mao, LM Gopal, N Jung, T Hennig, ... Blood 142 (25), 2175-2191, 2023 | | 2023 |
| Navtemadlin, a Novel MDM2 Inhibitor, Potentiated Venetoclax-Induced Antitumor Efficacy in TP53 Wild-Type Acute Myeloid Leukemia (AML) SC Nimmagadda, PK Patnana, PM Budde, H Ahmed, T Covey, C Krejsa, ... Blood 142, 2782, 2023 | | 2023 |
| Mutational Changes in Solid Cancer Cells Induce DNA Damage Repair Deficiency in Hematopoietic Cells Leading to a Distinct Spectrum of Clonal Hematopoiesis Independent from Age … T Leitner, A Künstner, M Kohl, T Barmwater, HM Ahmed, A Caliebe, ... Blood 142, 5605, 2023 | | 2023 |
| Dose‐dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL:: AF9‐induced leukaemic cells PK Patnana, L Liu, D Frank, SC Nimmagadda, M Behrens, H Ahmed, ... British Journal of Haematology 202 (5), 1033-1048, 2023 | | 2023 |
| BM-mesenchymal Stem Cell and Acute Myeloid Leukemia Cell Interaction: Wechselwirkung Zwischen Mesenchymalen Stammzellen Des Knochenmarks und Akuter Myeloischer Leukämiezellen HMM Ahmed Westfälische Wilhelms-Universität Münster, 2022 | | 2022 |
| Leukaemia Cells Induced Metabolic Alterations in AML Associated Mesenchymal Stem Cells Via Notch Signalling HMMA Noman, YS Al-Matary, SC Nimmagadda, PK Patnana, L Liu, L Wei, ... Blood 138, 4347, 2021 | | 2021 |
| Targeting PI3K-AKT-mTOR Signaling in Multiple Myeloma Mesenchymal Stem Cells Mediates Antiproliferative Effect on Myeloma Cells L Heinmann, HMMA Noman, K Möllers, SC Nimmagadda, K Sun, D Frank, ... Blood 138, 1600, 2021 | | 2021 |
| AML Associated Mesenchymal Stroma Cells Support Growth of AML Cells As a Result of Activated Notch Signaling and This Can be Targeted By Dexamethasone HMMA Ahmed, YS Al-Matary, SC Nimmagadda, M Fiori, PK Patnana, ... Blood 136, 1, 2020 | | 2020 |
| The interaction between Stroma and Multiple Myeloma K Möllers, H Noman, L Wei, A Poos, H Korab, D Frank, MS Raab, ... | | |
Cyrus KhandanpourDeputy Director, Department of Haematology and Oncology University Hospital Schleswig-HolsteinVerified email at uksh.de
